S.G. Hymowitz

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Andrew J. Souers, Erwin R. Boghaert, Scott Ackler et al. · Nature Medicine · 2013 · 2.9K citations

Thrombopoiesis, Thrombosis, Hematological Malignancy +11

Therapeutic antibody targeting of individual Notch receptors

Yan Wu, Carol Cain-Hom, Lisa Choy et al. · Nature · 2010 · 710 citations · Full text

Immunology, Receptor (Biochemistry), Immunochemistry +5

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL

Klaus W. Wagner, Elizabeth A. Punnoose, Thomas Januario et al. · Nature Medicine · 2007 · 602 citations

Cancer Research, G Protein-coupled Receptor, Medicine +9

IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding

S.G. Hymowitz · The EMBO Journal · 2001 · 553 citations · Full text

Inflammation, Cytokine, Autoimmune Disease +11

Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies

Kim Newton, M Matsumoto, Ingrid E. Wertz et al. · Cell · 2008 · 550 citations · Full text

Ubiquitin Chain Editing, Autoimmune Disease, Immunology +4